Protein Intake Plus Neuromuscular Electrical Stimulation on Muscle Mass in Hospitalized Elderly

Sponsor
University of Sao Paulo General Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT05008705
Collaborator
(none)
40
1
2
13.2
3

Study Details

Study Description

Brief Summary

This study aims to investigate the effects of supplementation of protein plus sessions of electrostimulation on muscle mass, length of hospital stay, readmission and mortality of hospitalized elderly.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: Protein supplementation
  • Device: Neuromuscular electrostimulation.
  • Dietary Supplement: Placebo (isocaloric supplement)
  • Device: Sham for neuromuscular electrostimulation.
N/A

Detailed Description

Hospitalized elderly people show malnutrition, physical inactivity, and pronounced systemic inflammation which may be exacerbated the catabolic state and promote drastic muscle wasting during the hospitalization and, thus increasing the length of stay, morbidity, and mortality. Therefore, the aim of this study is to investigate the effects of supplementation of protein plus sessions of electrostimulation on muscle mass, length of hospital stay, readmission, and mortality of hospitalized elderly.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Treatment
Official Title:
Effects of Protein Intake Plus Neuromuscular Electrical Stimulation on Muscle Mass in Hospitalized Elderly: a Randomized Controlled Clinical Study
Actual Study Start Date :
Aug 25, 2021
Anticipated Primary Completion Date :
Oct 1, 2022
Anticipated Study Completion Date :
Oct 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention

Patients allocated to this arm will be submitted to intervention (protein supplementation plus neuromuscular electrostimulation).

Dietary Supplement: Protein supplementation
Patients will receive diary 2 doses of the protein supplement

Device: Neuromuscular electrostimulation.
Patients will receive diary sessions of neuromuscular electrostimulation.

Placebo Comparator: Placebo

Patients allocated to this arm will be submitted to a placebo intervention (isocaloric supplement plus sham for neuromuscular electrostimulation).

Dietary Supplement: Placebo (isocaloric supplement)
Patients will receive diary 2 doses of the isocaloric supplement

Device: Sham for neuromuscular electrostimulation.
Patients will not receive neuromuscular electrostimulation.

Outcome Measures

Primary Outcome Measures

  1. Vastus Lateralis Muscle Cross-sectional Area [From date of admission until the date of medical discharge. Up to 30 days.]

    Vastus Lateralis Muscle Cross-sectional Area will be assessed through ultrasound

Secondary Outcome Measures

  1. Muscle function [From date of admission until the date of medical discharge. Up to 30 days.]

    Muscle function evaluated trough battery of test

  2. Nutritional status [From date of admission until the date of medical discharge. Up to 30 days.]

    Nutritional status will be assessed through nutritional records during hospital stay

  3. Handgrip strength [From date of admission until the date of medical discharge. Up to 30 days.]

    Strength will be evaluated using handgrip strength test

  4. Functional independence [From date of admission until the date of medical discharge. Up to 30 days.]

    Functional independence will be assessed using Barthel Index

  5. Length of hospital stay [From date of admission until the date of medical discharge. Up to 30 days.]

    Length of hospital stay will be the time (in days) until medical discharge.

  6. Mortality [From date of admission until the date of medical discharge. Up to 30 days.]

    Mortality rate in percent

  7. Hospital readmission post-medical discharge [6 months post-medical discharge]

    Hospital readmission post-medical discharge will be the number of times that he is admitted in the hospital post-medical discharge.

  8. Health costs [6 months post-medical discharge]

    Health costs will be estimated by means of the questionnaire with questions about the use of health services or equipment.

Eligibility Criteria

Criteria

Ages Eligible for Study:
65 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • both sex;

  • 65 years and older;

  • hospital stay less than 48 hours;

Exclusion Criteria:
  • cancer in the last 5 years;

  • delirium;

  • cognitive deficit that impossibility the patient to read and sign the informed consent form;

  • neurological disease;

  • neurodegenerative muscular disease;

  • impossibility to receive the intervention.

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Sao Paulo São Paulo Brazil 05508-030

Sponsors and Collaborators

  • University of Sao Paulo General Hospital

Investigators

  • Principal Investigator: Hamilton Roschel, PhD, University of Sao Paulo General Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Hamilton Augusto Roschel da Silva, Principal Investigator, University of Sao Paulo General Hospital
ClinicalTrials.gov Identifier:
NCT05008705
Other Study ID Numbers:
  • CAAE43707021.5.0000.0068
First Posted:
Aug 17, 2021
Last Update Posted:
Oct 5, 2021
Last Verified:
Sep 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 5, 2021